Limited Offer: Save €100 Today - Use Code: JKL70G
Medication

Semaglutide side effects: what to expect?

Learn how to identify and manage the side effects of semaglutide to ensure your weight loss journey is both comfortable and successful.

Semaglutide, the active ingredient in Ozempic and Wegovy, helps many people achieve significant weight loss. But like all medications, semaglutide has side effects. This article explains the most common side effects, when they subside, which symptoms are serious, and what you can do to alleviate them. This way, you will know exactly what to look out for.

What are the most common side effects of semaglutide?

The most common side effects of semaglutide are gastrointestinal. Nausea affects approximately 44 percent of Wegovy users, followed by diarrhea (30 percent), vomiting (25 percent), and constipation (24 percent). These symptoms are directly related to the mechanism of action of semaglutide: the medication slows down gastric emptying, which keeps food in the stomach longer. This suppresses appetite but can also cause discomfort. Other frequently reported side effects include headache, fatigue, and a slightly elevated heart rate. A small number of users also experience temporary hair loss, which is likely related to rapid weight loss rather than the medication itself.

When do semaglutide side effects subside?

For most users, side effects decrease significantly after four to eight weeks. The body gradually adjusts to the altered gastric emptying and increased GLP-1 activity. The Wegovy dosing schedule, where the dose is gradually increased from 0.25 mg to a final dose of 2.4 mg per week, is designed for this very reason. Those who follow the titration schedule as instructed generally experience significantly fewer symptoms than those who start treatment abruptly with a higher dose. According to studies, only 4.5 percent of semaglutide users in the STEP 1 study discontinued treatment due to gastrointestinal symptoms, compared to 0.8 percent in the placebo group.

Does semaglutide have serious side effects?

Yes, but they are rare. The most significant serious side effect is inflammation of the pancreas (pancreatitis). Symptoms include severe, persistent abdominal pain that may sometimes radiate to the back, as well as nausea or vomiting. If these symptoms occur, use of semaglutide must be stopped immediately and a doctor should be contacted. Additionally, there is an increased risk of gallstones, especially in connection with rapid weight loss. A safety review of semaglutide statesthat gallstones are the most significant serious side effect in long-term use. Another rare side effect is an eye condition called NAION, which can impair vision; it occurs in approximately one patient per 10,000 per year. Furthermore, severe dehydration caused by persistent vomiting or diarrhea can lead to kidney problems.

What are the long-term side effects?

In the long term, side effects of semaglutide are relatively rare. The most commonly reported are gallstones, which occur more frequently in people experiencing rapid and significant weight loss, as well as fatigue during the first months of treatment. According to a meta-analysis of four clinical trials, patients using semaglutide who did not have diabetes had a 1.59 times higher risk of experiencing gastrointestinal symptoms than those who received a placebo, but serious long-term side effects remained minimal. Goodweigh actively monitors patients through regular check-ups to ensure any potential symptoms are detected at an early stage.

How can semaglutide side effects be reduced?

There are several practical ways to significantly reduce symptoms. Eating slowly, taking small portions, and avoiding fatty or heavily spiced meals help reduce strain on the stomach. Adequate hydration is important, especially in the event of diarrhea or vomiting. Intense exercise immediately after an injection can worsen nausea; a gentle walk after a meal is a better option. However, if symptoms persist, the dosage titration can be temporarily slowed down by staying on a lower dose for a longer period. In the Goodweigh program, you receive tailored guidance for such symptoms so that you do not have to make decisions about your dosage alone.

When should semaglutide use be discontinued due to side effects?

Discontinue use if you experience severe and persistent abdominal pain, severe dehydration that does not improve with fluid intake, difficulty swallowing or breathing, or an allergic reaction such as a rash or swelling of the lips. You must also contact a doctor immediately if you notice yellowing of the skin or eyes, or a significant decrease in urine output. In less acute cases, such as persistent nausea that interferes with daily activities, Goodweigh will work with you to decide whether to temporarily reduce your dosage or pause treatment.

Does semaglutide differ from other GLP-1 medications in terms of side effects?

The side effect profile of semaglutide is very similar to the weight management medication Saxenda, which contains the active ingredient liraglutide. There is one significant difference, however: semaglutide is administered weekly, whereas liraglutide must be injected daily. The higher peak concentrations of a daily medication can cause more acute symptoms, while the weekly dose of semaglutide ensures a more stable concentration in the blood. A large-scale meta-analysis published in the British Medical Journal showsthat gastrointestinal symptoms are the most common side effect across the entire GLP-1 drug class, but the profile varies depending on the medication and dosage. Wegovy for weight loss and Ozempic for type 2 diabetes contain the same active ingredient, semaglutide, but they are intended for different indications and dosages.

Side effects are not necessarily a reason to stop treatment

Most side effects of semaglutide are mild, transient, and easily managed. They are most intense during the first few weeks of treatment as your body adjusts to the medication. With proper guidance, you can get through this phase and achieve lasting results. Would you like to know more about how semaglutide works or what the side effects of Ozempicare? Goodweigh is here to support you at every step of your treatment.

Viitteet

  • Smits, M. M., & Van Raalte, D. H. (2021). Safety of semaglutide. Frontiers in Endocrinology, 12, 645563. https://doi.org/10.3389/fendo.2021.645563
  • Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  • Tan, H. C., Dampil, O. A., & Marquez, M. M. (2022). Efficacy and safety of semaglutide for weight loss in obesity without diabetes: a systematic review and meta-analysis. Journal of the ASEAN Federation of Endocrine Societies, 37(2), 65–72. https://doi.org/10.15605/jafes.037.02.14
  • Yao, H., Zhang, A., Li, D., Wu, Y., Wang, C. Z., Wan, J. Y., & Yuan, C. S. (2024). Comparative efficacy of GLP-1 receptor agonists on glycemic control, weight management, and lipid profile in type 2 diabetes: a systematic review and network meta-analysis. BMJ, 384, e076410. https://doi.org/10.1136/bmj-2023-076410